Bioventus (BVS) Free Cash Flow (2020 - 2026)

Bioventus (BVS) has 7 years of Free Cash Flow data on file, last reported at $8.4 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 143.14% year-over-year to $8.4 million; the trailing twelve-month figure through Mar 2026 stood at $102.3 million (up 315.63% YoY), and the FY2025 full-year result was $74.4 million, up 96.97% from the prior year.
• Free Cash Flow for Q1 2026 stood at $8.4 million, down from $37.9 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $37.9 million in Q4 2025 and bottomed at -$24.0 million in Q2 2022.
• The 5-year median for Free Cash Flow is $8.4 million (2026), against an average of $6.9 million.
• The widest annual swing landed in 2022, when Free Cash Flow soared 5486.6%; it then tumbled 488.41% in 2024.
• A 5-year view of Free Cash Flow shows it stood at $11.7 million in 2022, then plunged by 63.04% to $4.3 million in 2023, then soared by 326.99% to $18.4 million in 2024, then soared by 105.9% to $37.9 million in 2025, then tumbled by 77.86% to $8.4 million in 2026.
• The last three Free Cash Flow figures came in at $8.4 million (Q1 2026), $37.9 million (Q4 2025), and $31.4 million (Q3 2025), per Business Quant data.

Peer Comparison